|
Found 23 result(s) FROM 1963 pages containing the term 'myelodysplastic syndrome'.
Friday Apr 02, 2010
Spotlight on Sjögren's Syndrome
As many as 4 million Americans are affected by the autoimmune disorder, but most suffer from symptoms for 3 or more years before receiving an accurate diagnosis...
Wednesday Aug 05, 2009
Lupus with Leucopenia, Anemia Signals Risk of Leukemia
Lupus patients with persistent leucopenia or anemia may be at risk for myeloid leukemia...
Thursday Jul 31, 2008
Altered Intestinal Permeability in Patients with Primary Fibromyalgia or Complex Regional Pain Syndrome
Researchers discovered that intestinal permeability may be increased in both fibromyalgia and complex regional pain syndrome (CRPS) patients, which can lead to immune modulation…
Friday Mar 28, 2008
Regeneron’s Arcalyst™ (rilonacept), First and Only FDA-Approved Treatment for Cryopyrin-Associated Periodic Syndromes (CAPS); Now Available in the US
Regeneron Pharmaceuticals, Inc announced that Arcalyst™ (rilonacept) injection for subcutaneous use is now available by prescription in the US for the treatment of cryopyrin-associated periodic syndromes (CAPS)...
Tuesday Feb 26, 2008
ADHD Drugs Linked to Raynaud's Syndrome in Children
CNS stimulants used to treat ADHD have been linked to development of Raynaud's syndrome in children...
Tuesday Jan 29, 2008
Association Between Psoriasis and the Metabolic Syndrome
Researchers have found a possible association between psoriasis and the metabolic syndrome, and have suggested possible new treatment options for the management of psoriasis...
Monday Nov 19, 2007
Early Surgery Trumps Steroids for Long-Term Outcomes in Carpal Tunnel Syndrome
Decompression surgery is three times more effective than local corticosteroid injections for primary carpal syndrome...
Friday Oct 05, 2007
Future Looks Bright for Sjögren's Syndrome Patients
B- and T-cell targeted therapies as well as other biologic drugs may change the way primary Sjögren's syndrome is treated in the future...
Tuesday Aug 07, 2007
Medarex Announces Initiation by Licensing Partner Novartis of Phase III Clinical Trial for Muckle-Wells Syndrome, a Rare Inherited Autoinflammatory Disease
Medarex, Inc announced that Novartis Pharmaceuticals AG has advanced ACZ885, a fully human monoclonal antibody targeting interleukin-1β (IL-1 β), to a phase III clinical trial for Muckle-Wells syndrome (MWS), an inherited systemic autoinflammatory disease...
Thursday Jul 26, 2007
Vitamin C After Wrist Fracture Prevents Chronic Pain Syndrome
Vitamin C (500 mg/day) taken for 50 days after wrist fracture significantly reduces the risk of developing complex regional pain syndrome...
Thursday May 24, 2007
Single Local Corticosteroid Injection Is the Most Effective Way to Avoid Surgery in Severe Carpal Tunnel Syndrome
An updated review of 12 studies comprising 671 patients found that local corticosteroid injections can provide at least a month of relief for patients with severe carpal tunnel syndrome...
Tuesday Feb 20, 2007
New Research Links Carpal Tunnel Syndrome to Genes
Carpal tunnel syndrome appears to be less related to occupational activity than to genetics...
Thursday Dec 14, 2006
Transcranial Electrostim Reduces Pain, Confirms Fibromyalgia as a Central Pain Syndrome
Noninvasive transcranial direct current stimulation can relieve fibromyalgia pain, pilot study shows...
Wednesday Nov 01, 2006
Regeneron's Phase III Clincial Program for Interleukin-1 (IL-1) Trap, a Long Lasting IL-1 Inhibitor, Achieves Primary Endpoints in Studies with Patients Diagnosed with CAPS, a Spectrum of Rare Chronic Autoinflammatory Syndromes
Regeneron Pharmaceuticals, Inc, announced positive data from a phase III clinical program designed to provide two separate demonstrations of efficacy for the investigational drug Interleukin-1 (IL-1) Trap within a single group of patients suffering from CAPS (CIAS1-related Autoinflammatory Periodic Syndromes).
Thursday Oct 26, 2006
New Study Casts Doubt on Metabolic Dysfunction in Chronic Fatigue Syndrome
A new study comparing response to exercise in patients with chronic fatigue syndrome (CFS) and fibromyalgia (FM) finds exercise more difficult in CFS/FM patients than in those with CFS alone, but casts doubt on metabolic explanations for CFS…Cook DB, et al. Arthritis Rheum. 2006;54:3351–3362.
Wednesday Jul 19, 2006
Metabolic Syndrome Correlates With High Disease Activity in RA
Metabolic syndrome correlates with higher disease severity in RA. Karvounaris SA, et al. Ann Rheum Dis; published online June 22, 2006.
Monday Jun 12, 2006
Regeneron's IL-1 Trap Receives Fast-Track Designation From US FDA for CIAS1-Associated Periodic Syndromes (CAPS)
Regeneron's IL-1 Trap has received fast-track designation from the US FDA for CIAS1-Associated Periodic Syndromes (CAPS), a family of rare autoinflammatory diseases...
Saturday Jun 10, 2006
Regeneron's IL-1 Trap Receives Fast-Track Designation from US FDA for CIAS1-Associated Periodic Syndromes (CAPS), a family of rare autoinflammatory diseases
Regeneron's IL-1 Trap Receives Fast-Track Designation from US FDA for CIAS1-Associated Periodic Syndromes (CAPS), a family of rare autoinflammatory diseases
Monday Mar 13, 2006
Steroids Not Beneficial for Genital Ulcers in Behçet's Syndrome
Low-dose depot corticosteroids do not have a beneficial effect on the genital ulcers of Behçet's syndrome, but they may help control erythema nodosum lesions—especially in females... Mat C, et al. Rheumatology. 2006;45:348-352.
Thursday Oct 20, 2005
Novel Hereditary Cartilage Debonding Syndrome Identified
Researchers have identified a new cartilage friability and osteochondral debonding syndrome that may provide insight into cartilage-bone interaction in other forms of joint degeneration ... Holderbaum D, et al. Arthritis Rheum. 2005;52:3300-3304.
Tuesday Aug 09, 2005
Neuropsychiatric Syndromes in SLE Patients Are Complex and Underdiagnosed
Though neuropsychiatric (NP) syndromes, regardless of etiology, are common among patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), a new study suggests that lupus patients with a history of NP syndromes report more severe anxiety and depression as well as cognitive dysfunction, pointing to the need for earlier diagnosis of these nonspecific symptoms...J Rheumatol. 2005;32:1459-1466.
Friday Jun 17, 2005
Immunomedics' Anti-CD22 Antibody Shows Promise for Sjogren's Syndrome
Immunomedics, Inc, reported encouraging initial safety and clinical efficacy results from its open-label, non-randomized, Phase I/II trial of epratuzumab for the treatment of patients with Sjogren's syndrome (ss).
Tuesday Nov 23, 2004
Large National Survey Shows Importance of Anxiety Disorders in the Psychopathology of Pain Syndromes
Recent findings add to an emerging body of data suggesting that anxiety may have a stronger association with arthritis and other pain conditions than depression& McWilliams LA, et al. Pain. 2004;111:77-83.
|
